3626 results for «513»

Filter By

3626 results

TAVI: Late-Breaking Trials and Innovations

27 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions, and learn more about the early safety and performance of the Vienna TAVI system, the new-generation transcatheter aortic valve platforms performance in native pure aortic regurgitation, and more!

TAVI: Late-Breaking Trials and Innovations

Patient selection for tricuspid valve interventions

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn more about the anatomical assessment of candidates for transcatheter tricuspid valve interventions, to understand the importance of detailed haemodynamic assessment in patients with severe tricuspid regurgitation and to discuss the predictors of clinical outcome after these interventions.

Patient selection for tricuspid valve interventions

Rapid-fire abstracts: session 4

27 Nov 2022 – From PCR London Valves 2022

In this PCR LV 2022 session dedicated to TAVI, take advantage of the 7 abstracts to learn more about the impact of TAVI for pure regurgitation on the severity of concomitant mitral regurgitation, the deformation of transcatheter heart valve and haemodynamics after aortic ViV, and much...

Rapid-fire abstracts: session 4

Transcatheter mitral valve intervention is progressing more slowly than expected: why is it happening? And what can we do? Root causes, challenges and opportunities

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn about the latest news in the field of mitral valve intervention and get insights into its current slow progress, which may be caused by clinical, anatomical or technological factors.

Transcatheter mitral valve intervention is progressing more slowly than expected: why is it happening? And what can we do? Root causes, challenges and opportunities

Is frailty still relevant after 20 years of TAVI?

28 Nov 2022 – From PCR London Valves 2022

Consult this session to gain further knowledge of the frailty syndrome, to understand its relevance in today's patient population and to learn how to measure it using validated tools.

Is frailty still relevant after 20 years of TAVI?

TAVI in complex situations - LIVE case

28 Nov 2022 – From PCR London Valves 2022

  • Part 1: TAVI with the presence of a mechanical mitral valve.
    An 80-year-old female with a history of mechanical mitral valve (25 On-X in 2015) presents severe symptomatic AS with preserved LV function. The operators implant a 25 mm Navitor, with predilatation (18 mm balloon) on wire pacing...
Transcatheter intervention for aortic valve disease: state of the art

Challenging scenarios: TAV-in-TAV procedures

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover some challenging TAV-in-TAV procedures, and learn more about the key role of imaging during pre-procedural work-up and the potential treatment options after TAVI bioprosthetic valve fracture.

Challenging scenarios: TAV-in-TAV procedures

Secondary mitral regurgitation: challenges in management

28 Nov 2022 – From PCR London Valves 2022

Consult this session dedicated to secondary mitral regurgitation to learn more about the patients who benefit most from valve intervention, the transcatheter edge-to-edge repair strategies in secondary MR and how to optimally select patients with secondary MR for valve replacement.

Secondary mitral regurgitation: challenges in management

TAVI-in-TAVI - A road map for successful lifetime management

29 Nov 2022 – From PCR London Valves 2022

Join a team of experts that guide you through the basics of TAVI-in-TAVI, the procedural planning and techniques of implantation, followed by case examples with different index prostheses.

TAVI-in-TAVI - A road

TAVI challenges: session 2

28 Nov 2022 – From PCR London Valves 2022

Watch this PCR LV 2022 session to learn how to treat TAVI with severe peripheral calcifications, a complex TAVI with extreme tortuous and horizontal aorta, or even TAVI in aortic regurgitation patient after failed attempt with commercial device. 

TAVI challenges: session 2

Rapid-fire abstracts: Session 6

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: hydrodynamic performance of ACURATE neo2 for valve-in-valve across different surgical bioprostheses, impact of leaflets splitting on coronary access after redo TAVI in failed supra-annular platforms, same-day discharge after TF and alternate access...

Rapid-fire abstracts: Session 6

Rapid-fire abstracts: Session 7

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: contemporary outcome of high surgical risk mitral regurgitation, quantitative flow ratio vs. FFR for coronary functional evaluation in patients undergoing TAVI, videodensitometric quantification of paravalvular leak after implantation of the new Myval-Octacor,...

Rapid-fire abstracts: Session 7

TAVI challenges: session 3

28 Nov 2022 – From PCR London Valves 2022

View a radial access balloon aortic valvuloplasty adapting to the challenge of small arteries, a semi-inflated buddy balloon for percutaneous TAVR in severe calcified bicuspid aortic valve, and long-term outcome of TAVR in mucopolysaccharidosis type I-HS in this PCR LV 2022 session, among others!

TAVI challenges: session 3

Rapid-fire abstracts: Session 9

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: impact of different aortic valve calcification pattern on the haemodynamic performance of self-expanding intra-annular transcatheter heart valve, device failure in bicuspid aortic stenosis following TAVR, the learning curve and clinical outcomes in...

Rapid-fire abstracts: Session 9

Mitral - Late-Breaking Trials and Innovations

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of late-breaking trials presented during PCR LV 2022: TENDyne European expeRience registry, CLASP IID trial, EXPAND G4, and much more!

Mitral - Late-Breaking

Transcatheter edge-to-edge mitral valve repair step by step: from transseptal puncture to procedural success

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn how to perform a mitral transcatheter edge-to-edge repair procedure from start to finish, to learn more about currently available devices and which one to use in specific patients, and to understand how optimal procedural imaging and device steering determine the best...

Transcatheter edge-to-edge mitral valve repair step by step: from transseptal puncture to procedural success

Imaging for mitral valve interventions

28 Nov 2022 – From PCR London Valves 2022

Thanks to this PCR LV 2022 session, find out more about outcome of patients undergoing transcatheter edge-to-edge mitral valve repair with HFpEF diagnosis.

Imaging for mitral valve interventions

Valve-in-valve TAVI: Session 2

28 Nov 2022 – From PCR London Valves 2022

Consult this session on Valve-in-valve TAVI to discover a selection of cases presented during PCR LV 2022: valve-in-valve TAVR status post ascending aorta and aortic arch replacement, valve-in-valve and endovascular treatment of aortic dissection in a Marfan patient, valve-in-valve TAVR in a freestyle root 25 mm through a severely...

Valve-in-valve TAVI: Session 2

TAVI in patients at risk of coronary occlusion

28 Nov 2022 – From PCR London Valves 2022

Consult this session on TAVI in patients at risk of coronary occlusion to discover a selection of cases presented during PCR LV 2022: hyperacute obstruction of the left main artery due to calcium displacement during TAVR, cannulation technique for challenging coronary access following TAVI-in-TAVI, complex TAVI from...

TAVI in patients at risk of coronary occlusion

Surgical and transcatheter tricuspid intervention: state of the art - LIVE case

29 Nov 2022 – From PCR London Valves 2022

In this PCR London Valves 2022 session, follow 3 stunning case treatments:

  • Part 1: Triscupid TEER (Live)
    A 78-year-old male with a history of CABG (2015), PM-CRT (2015) and atrial fibrillation, presents a severe TR with an LVEF of 40%, preserved RV function and moderate pulmonary hypertension.
    They performed...
Surgical and transcatheter tricuspid intervention: state of the art
Didn’t find what you were looking for?